Selective targeting of cancer cells in new treatment approach

Finding a way to make drugs act more selectively on cancer cells is the key to improving treatment success while reducing toxicity in children treated for high-risk leukaemia.

Related Keywords

Australia ,Australian , ,Children Cancer Institute ,Australian Centre For Nanomedicine ,Medicine Health ,Science Translational Medicine ,Professor Maria Kavallaris ,Cancer Institute ,Cancer ,Childrens Cancer Institute ,Nsw ,Leukaemia ,Igh Risk Leukaemias ,Chemotherapy ,Bispecific Antibodies ,